Tania Massignan
Trento, 38123, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Ligands binding to the prion protein induce its proteolytic release with therapeutic potential in neurodegenerative proteinopathies.
Journal: Science advances
Published: November 24, 2021
Pharmacological inactivation of the prion protein by targeting a folding intermediate.
Journal: Communications biology
Published: August 07, 2020
Identification of compounds inhibiting prion replication and toxicity by removing PrPC from the cell surface.
Journal: Journal of neurochemistry
Published: April 18, 2019
IL-7-induced phosphorylation of the adaptor Crk-like and other targets.
Journal: Cellular signalling
Published: March 16, 2018
A Small-Molecule Inhibitor of Prion Replication and Mutant Prion Protein Toxicity.
Journal: ChemMedChem
Published: May 18, 2017
A cationic tetrapyrrole inhibits toxic activities of the cellular prion protein.
Journal: Scientific reports
Published: October 12, 2015
Peptidylprolyl isomerase A governs TARDBP function and assembly in heterogeneous nuclear ribonucleoprotein complexes.
Journal: Brain : a journal of neurology
Published: February 14, 2015
A mutant prion protein sensitizes neurons to glutamate-induced excitotoxicity.
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: February 09, 2013
The N-terminal, polybasic region of PrP(C) dictates the efficiency of prion propagation by binding to PrP(Sc).
Journal: The Journal of neuroscience : the official journal of the Society for Neuroscience
Published: June 30, 2012
Showing 1-12 of 12
Last Updated: 09/26/2026